XML 22 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Inventories and Other Deferred Costs
6 Months Ended
Jun. 30, 2017
Text Block [Abstract]  
Inventories and Other Deferred Costs
3.   Inventories and Other Deferred Costs

Inventories and other deferred costs consist of the following:

 

     June 30, 2017      December 31, 2016  
     (in thousands)  

Raw materials

   $ 3,573      $ 2,810  

Work-in-process

     2,934        2,489  

Finished products

     11,618        11,662  

Other deferred costs

     2,338        2,617  
  

 

 

    

 

 

 

Total inventory

   $ 20,463      $ 19,578  
  

 

 

    

 

 

 

We had inventory on consignment of $1.3 million and $1.1 million at June 30, 2017 and December 31, 2016, respectively.

In connection with our recent acquisition of the RestoreFlow allograft business, other deferred costs include costs incurred for the preservation of human vascular tissue available for shipment, tissue currently in active processing, and tissue held in quarantine pending release to implantable status. By federal law, human tissue cannot be bought or sold. Therefore, the tissue we preserve are not held as inventory, and the costs we incur to procure and process vascular tissue are instead accumulated and deferred.